Prediction of hepatocellular carcinoma recurrence beyond Milan criteria after resection: Validation of a clinical risk score in an international cohort
Annals of Surgery Sep 18, 2017
Zheng J, et al. - Authors performed this study to validate a previously reported recurrence clinical risk score (CRS). In this study, CRS accurately predicted hepatocellular carcinoma (HCC) recurrence beyond Milan criteria (MC). Although the risk of recurrence beyond MC decreased over time, it never reached zero.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
